Volume 9 Number 5

Editorial

A sense of “déjà vu”?

Serruys PW

10.4244/EIJV9I5A87

free

What is microRNA and should interventionalists be aware of it?

Zhang C

10.4244/EIJV9I5A88

free

Clinical research

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y, Zhong S-L

10.4244/EIJV9I5A90

free

Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique

Nijhoff F, Agostoni P, Samim M, Ramjankhan F, Kluin J, Doevendans P, Stella P

10.4244/EIJV9I5A91

free

Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Schwalm T, Carlsson J, Meissner A, Lagerqvist B, James S

10.4244/EIJV9I5A92

free

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S

10.4244/EIJV9I5A93

free

A new methodology for accurate 3-dimensional coronary artery reconstruction using routine intravascular ultrasound and angiographic data: implications for widespread assessment of endothelial shear stress in humans

Bourantas C, Papafaklis M, Athanasiou L, Kalatzis F, Naka K, Siogkas P, Takahashi S, Saito S, Fotiadis D, Feldman C, Stone P, Michalis L

10.4244/EIJV9I5A94

free

First-in-human experience using the Volcano VIBE-RX vascular imaging balloon catheter system (Volcano IVUS-guided Balloon Evaluation - New Zealand: VIBE-NZ Study)

Watson T, El-Jack S, Stewart J, Ormiston J

10.4244/EIJV9I5A95

free

Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography

Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S

10.4244/EIJV9I5A96

free

No indication for an unexpected high rate of coronary artery aneurysms after angioplasty with drug-coated balloons

Kleber F-X, Schulz A, Bonaventura K, Fengler A

10.4244/EIJV9I5A97

free

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial

Waksman R, Serra A, Loh J, Malik F, Torguson R, Stahnke S, Von Strandmann R, Rodríguez A

10.4244/EIJV9I5A98

free

Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?

Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Borger MA, Degenhardt R, Scheller B

10.4244/EIJV9I5A99

free

Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale

Freixa X, Ibrahim R, Chan J, Garceau P, Dore A, Marcotte F, Mercier L-A, Pierre-Mongeon F, Basmadjian A, Khairy P, Asgar A

10.4244/EIJV9I5A100

free